Virginia Wealth Management Group, Inc. Pfizer Inc Transaction History

Virginia Wealth Management Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $71,721 - $83,834	-2,235 Reduced 11.96%	16,445 $545,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $2,167 - $2,507	-60 Reduced 0.32%	18,680 $685,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $512 - $666	13 Added 0.07%	18,740 $764,000
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $30,644 - $40,003	-734 Reduced 3.77%	18,727 $959,000
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $105,286 - $128,528	-2,406 Reduced 11.0%	19,461 $852,000
Q2 2022 Jan 04, 2023	SELL	$46.53 - $55.17 $677,849 - $803,716	-14,568 Reduced 74.86%	4,893 $257,000
Q2 2022 Jan 04, 2023	BUY	$46.53 - $55.17 $1.02 Million - $1.21 Million	21,867 Added 446.9%	26,760 $1.4 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $766,535 - $908,870	16,474 Added 305.47%	21,867 $1.15 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $9,150 - $11,338	-200 Reduced 3.58%	5,393 $292,000
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $231,102 - $342,571	5,593 New	5,593 $330,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.